BUCCIARELLI, PAOLO
BUCCIARELLI, PAOLO
Universita' degli Studi di MILANO
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
2022 G. Palareti, D. Poli, W. Ageno, C. Legnani, E. Antonucci, E. Bucherini, S. Testa, O. Paoletti, A. Chistolini, A. Serrao, I. Martinelli, P. Bucciarelli, A. Falanga, A. Tosetto, L. Sarti, D. Mastroiacovo, B. Cosmi, A. Visonà, R.C. Santoro, N. Zanatta, E. Grandone, L. Bertù, V. Pengo, L. Caiano, P. Prandoni
Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit
2022 R. Gualtierotti, F. Tafuri, R. Rossio, M. Rota, P. Bucciarelli, B. Ferrari, A. Giachi, C. Suffritti, M. Cugno, F. Payvandi
ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis
2021 M.T. Pagliari, M. Boscarino, A. Cairo, I. Mancini, I. Martinelli, P. Bucciarelli, F. Rossi, F.R. Rosendaal, F. Peyvandi
Plasma levels of extracellular vesicles and the risk of post-operative pulmonary embolism in patients with primary brain tumors: a prospective study
2021 S.M. Passamonti, A. Artoni, G. Carrabba, G. Merati, M. Abbattista, M. Capecchi, M. Castellani, C. Marenghi, E. Trombetta, L. Giammattei, M. Caroli, P. Bucciarelli, E. Scalambrino, F. Peyvandi, I. Martinelli
Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis
2021 M.T. Pagliari, A. Cairo, M. Boscarino, I. Mancini, E. Pappalardo, P. Bucciarelli, I. Martinelli, F.R. Rosendaal, F. Peyvandi
Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease
2020 F. Stufano, L. Baronciani, P. Bucciarelli, M. Boscarino, P. Colpani, M.T. Pagliari, F. Peyvandi
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A
2020 F. Peyvandi, S. Miri, P. Bucciarelli, C. Valsecchi, L. Schiavone, M. Boscarino, R. Palla, P.M. Mannucci, F.R. Rosendaal
Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura
2020 P. Agosti, I. Mancini, F. Gianniello, P. Bucciarelli, A. Artoni, B. Ferrari, S. Pontiggia, S.M. Trisolini, L. Facchini, C. Carbone, F. Peyvandi
Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome
2019 F. Stufano, M. Boscarino, P. Bucciarelli, L. Baronciani, A. Maino, G. Cozzi, F. Peyvandi
Validation of the Predictive Model of the European Society of Cardiology for Early Mortality in Acute Pulmonary Embolism
2018 M. Cugno, F. Depetri, L. Gnocchi, F. Porro, P. Bucciarelli
Targeted sequencing to identify novel genetic risk factors for deep vein thrombosis: a study of 734 genes
2018 H.G. de Haan, A. van Hylckama Vlieg, L.A. Lotta, M.M. Gorski, P. Bucciarelli, I. Martinelli, T.P. Baglin, F. Payvandi, F.R. Rosendaal, P. Amouyel, M. de Andrade, S. Basu, C. Berr, J.A. Brody, D.I. Chasman, J.-. Dartigues, A.R. Folsom, M. Germain, J. Heit, J. Houwing-Duitermaat, C. Kabrhel, P. Kraft, G. Le Gal, S. Lindström, R. Monajemi, P.-. Morange, B.M. Psaty, P.H. Reitsma, P.M. Ridker, L.M. Rose, N. Saut, E. Slagboom, D. Smadja, N.L. Smith, P. Suchon, W. Tang, K.D. Taylor, D.-. Trégouët, C. Tzourio, M.C.H. de Visser, L.-. Weng, K.L. Wiggins
Risk of post-operative venous thromboembolism in patients with meningioma
2018 G. Carrabba, M. Riva, V. Conte, A. Di Cristofori, M. Caroli, M. Locatelli, M. Castellani, P. Bucciarelli, A. Artoni, N. Stocchetti, I. Martinelli, P. Rampini
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia
2018 G. Reda, R. Cassin, A. Artoni, B. Fattizzo, A. Lecchi, S. La Marca, P. Bucciarelli, G.V. Levati, F. Peyvandi, A. Cortelezzi
Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis
2018 M.M. Gorski, H.G. de Haan, I. Mancini, L.A. Lotta, P. Bucciarelli, S.M. Passamonti, A. Cairo, E. Pappalardo, A. van Hylckama Vlieg, I. Martinelli, F.R. Rosendaal, F. Peyvandi
Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis
2018 A. Artoni, M. Abbattista, P. Bucciarelli, F. Gianniello, E. Scalambrino, E. Pappalardo, F. Peyvandi, I. Martinelli
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
2018 I. Martinelli, M. Abbattista, P. Bucciarelli, A. Tripodi, A. Artoni, F. Gianniello, C. Novembrino, F. Peyvandi
Hemostatic abnormalities in patients with Ehlers–Danlos syndrome
2018 A. Artoni, A. Bassotti, M. Abbattista, B. Marinelli, A. Lecchi, F. Gianniello, M. Clerici, P. Bucciarelli, S. La Marca, F. Payvandi, I. Martinelli
Minimal factor XIII activity level to prevent major spontaneous bleeds : reply
2017 M. Menegatti, R. Palla, P. Bucciarelli, F. Peyvandi
Idelalisib Rapidly Improves Platelets Function in Patients with Chronic Lymphocytic Leukemia (CLL)
2016 G. Reda, R. Cassin, A. Artoni, A. Lecchi, B. Fattizzo, S. LA MARCA, P. Bucciarelli, F. Payvandi, A. Cortelezzi
Pregnancy outcome after a first episode of cerebral vein thrombosis
2016 I. Martinelli, S.M. Passamonti, A. Maino, M. Abbattista, P. Bucciarelli, E. Somigliana, A. Artoni, F. Gianniello, F. Peyvandi